Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000895345-15-000266
Filing Date
2015-10-05
Accepted
2015-10-05 16:39:33
Documents
1
Group Members
ROBERTO MIGNONE

Document Format Files

Seq Description Document Type Size
1 SC 13G ja13g-tg-bridger.htm SC 13G 53635
  Complete submission text file 0000895345-15-000266.txt   55545
Mailing Address 787 SEVENTH AVENUE NEW YORK NY 10019
Business Address 787 SEVENTH AVENUE NEW YORK NY 10019 (212) 554-4484
TG THERAPEUTICS, INC. (Subject) CIK: 0001001316 (see all company filings)

EIN.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-51051 | Film No.: 151143764
SIC: 2834 Pharmaceutical Preparations

Mailing Address 90 PARK AVENUE, 40TH FLOOR NEW YORK NY 10016
Business Address 90 PARK AVENUE, 40TH FLOOR NEW YORK NY 10016 212-918-0820
BRIDGER MANAGEMENT, LLC (Filed by) CIK: 0001166309 (see all company filings)

EIN.: 582553507 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G